# Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules

> **NCT06848907** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Dong Hui** · enrollment: 138 (estimated)

## Conditions studied

- MAFLD

## Interventions

- **DRUG:** ganzhixiao capsule
- **DRUG:** placebo capsule

## Key facts

- **NCT ID:** NCT06848907
- **Lead sponsor:** Dong Hui
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2028-05-30
- **Final completion:** 2028-05-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06848907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06848907, "Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06848907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*